Colgate-Palmolive Stock - Analyst consensus remains supportive

Colgate-Palmolive stock continues to trade near record territory while Wall Street consensus stays broadly positive. Here is how analysts rate the shares, what targets they see, and where the valuation stands in the consumer staples sector.

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/17/2026, 16:30 UTC. Details in the imprint.

Colgate-Palmolive (US1941621039) remains a steady defensive name in US consumer staples. Consensus data show that most Wall Street analysts still rate the stock positively, with limited signs of capitulation despite the strong run over recent months.

What the analyst data show

According to Google Finance, 18 Wall Street analysts currently provide 12-month price targets for Colgate-Palmolive, with an average target of $105 and a high estimate also at $105, compared with a recent price around $90.66. The same overview indicates that the average target implies low double-digit upside from current levels.

The overall rating distribution remains skewed toward positive recommendations, with most brokers in the Buy or Overweight camp and a smaller group on Hold. This pattern underscores that, despite the stock’s strong multi-month performance, consensus still treats Colgate-Palmolive as a relatively attractive compounder in the staples space.

How the valuation stacks up

MarketBeat data show Colgate-Palmolive shares trading near $90.56 at the close on 06/16/2026, up from $79.02 at the start of the year, an increase of roughly 14.6%. The same snapshot puts the company’s market capitalization around the mid tens of billions of dollars.

On conventional measures, Colgate-Palmolive trades at a premium to the broader market, reflecting its high-margin oral care franchise and resilient cash flows. GuruFocus estimates a proprietary GF Value of about $93.66 per share, suggesting the stock is modestly undervalued by roughly 3.2% on that metric. The same analysis also flags the stable profitability profile that supports this valuation.

What the company sells

Colgate-Palmolive generates most of its revenue from oral care, led by its global Colgate branded toothpaste and toothbrush portfolio. It complements this with personal care and home care products under brands such as Palmolive and Softsoap, and a sizeable pet nutrition segment via Hill’s.

Where the stock trades today

Colgate-Palmolive shares (US1941621039) trade on the New York Stock Exchange under the ticker CL at about $90.56 as of 06/16/2026, 15:59 ET.

Key facts on Colgate-Palmolive stock

• Company: Colgate-Palmolive Company
• ISIN: US1941621039
• WKN: 850667
• Ticker: CL
• Venue: NYSE
• Price (as of 06/16/2026, 15:59 ET): 90.56 USD
• Market cap: around 74,000,000,000 USD (as of 06/16/2026)
• Sector / Industry: Consumer Staples / Household & Personal Products
• Index membership: Standard & Poor's 500 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.